Human papillomavirus infection and cardiovascular mortality: a cohort study
Graphical Abstract Sample Work
Cardiovascular diseases (CVDs are the leading cause of global mortality despite advances in managing conventional risk factors, with many cases occurring in individuals without these risks. This highlights the need to identify additional modifiable determinants. Human papillomavirus (HPV), a common sexually transmitted infection and established cause of anogenital cancers, has been increasingly linked to atherosclerotic CVD. However, evidence on long-term cardiovascular outcomes remains limited. This large cohort study of Korean women examined the association between high-risk HPV infection and CVD mortality, with consideration of potential effect modification by obesity.
Three tiers for three questions
This graphical abstract summarises a large cohort study of Korean women that examined whether high-risk human papillomavirus (HR-HPV) infection is associated with cardiovascular mortality, and whether obesity modifies that association. The layout stacks three horizontal tiers, each answering a different question: who was studied and for how long; how mortality rates compared between infected and uninfected women; and whether the pattern differed by body mass index. The audience includes cardiologists, epidemiologists, gynaecologists and public health researchers.
An infection known for cancer, examined for heart disease
Cardiovascular disease is the leading cause of death worldwide, and a substantial share of events occurs in people without conventional risk factors such as hypertension or raised cholesterol. That gap drives interest in additional, potentially modifiable determinants. HPV is a very common sexually transmitted infection and an established cause of cervical and other anogenital cancers. Some studies have linked it to atherosclerotic cardiovascular disease, possibly through chronic inflammation, but evidence on long-term cardiovascular deaths has been limited.
A cohort that tests women for HR-HPV and follows them for many years through national death records can address that gap, and the study's inclusion of obesity reflects the possibility that metabolic and inflammatory risks combine.
Tier one: the cohort in a single sentence
The top banner introduces the population as 163,250 Korean women tested for HR-HPV infection, with a map silhouette of Korea and a female profile. A dashed arrow labelled "Follow for up to 17 years" leads to an icon of a record and the text "Identifying cardiovascular disease mortality through national death records". In one line, readers learn the sample size, exposure, follow-up duration and outcome ascertainment, which together signal a well-powered cohort with objective endpoints.
Putting this information first is a deliberate sequencing choice. Cardiovascular deaths in relatively young, screened women are uncommon, so the reader needs to know early that the cohort was very large and followed for a long period; otherwise the small absolute rates in the next tier could look implausible. Linking outcomes to national death records also tells readers that deaths were identified systematically rather than through self-report or loss to follow-up.
Tier two: paired mortality rates with hazard ratios between them
The middle tier compares women without HR-HPV (green arrow) and women with HR-HPV (red arrow) across three outcomes. Rates are given per 105 person-years, with the hazard ratio placed between each pair:
| Outcome | Without HR-HPV | With HR-HPV | HR (95% CI) |
|---|---|---|---|
| Atherosclerotic CVD mortality | 1.9 | 7.1 | 3.91 (1.85–8.26) |
| Ischaemic heart disease mortality | 1.4 | 5.0 | 3.74 (1.53–9.14) |
| Stroke mortality | 0.3 | 1.4 | 5.86 (0.86–40.11) |
The stroke estimate deserves careful reading. Although the point estimate is the largest of the three, its confidence interval is very wide and includes 1, which indicates imprecision because few stroke deaths occurred. Presenting the interval in the figure, rather than only the hazard ratio, allows readers to see this for themselves.
Tier three: obesity as an effect modifier
The bottom band divides women by BMI, with obese women (BMI ≥25 kg/m², the threshold commonly used in Asian populations) on the left and non-obese women (BMI <25 kg/m²) on the right. A central box explains that the values are atherosclerotic CVD mortality rates in women with versus without HR-HPV infection.
- Obese women: 24.5 versus 4.2 per 105 person-years; HR 4.81 (95% CI 1.55–14.93).
- Non-obese women: 4.1 versus 1.5 per 105 person-years; HR 2.86 (95% CI 1.04–7.88).
The absolute rate among obese women with HR-HPV stands out as markedly higher, which is the visual point of the tier. The mirrored layout, with an illustrated woman at each end, makes the comparison symmetrical and easy to scan.
Reporting cautions and how to adapt the design
Observational cohort studies are reported against the STROBE statement, and their graphical abstracts should describe associations rather than causes. This figure keeps to that by presenting rates and hazard ratios without causal wording. Readers should remember that very low absolute rates can produce large relative estimates. This page is a writing sample, not medical advice about HPV or cardiovascular risk.
The three-tier layout works well for any cohort with a main association and a subgroup analysis. Pubrica produces such figures through its graphical abstract service, and the same findings can be rewritten for patients and the public as a plain language summary.
Questions about this sample
Why are mortality rates shown per 100,000 person-years?
Person-years account for the different lengths of time each woman was followed, up to 17 years. Expressing rates per 100,000 person-years makes rare outcomes such as cardiovascular death comparable between groups of different sizes and follow-up durations, and allows absolute risks to be shown alongside the hazard ratios.
Is the association between HR-HPV and stroke mortality statistically clear?
Not on its own. The hazard ratio of 5.86 has a 95% confidence interval from 0.86 to 40.11, which includes 1. This wide interval reflects the small number of stroke deaths. The figure shows the interval so readers can judge the precision of this estimate rather than relying on the point estimate alone.
Why does the figure use a BMI cut-off of 25 for obesity?
The study classified obesity as a BMI of 25 kg/m2 or higher, which is the threshold commonly applied in Asian populations, including Korea. The bottom tier uses this cut-off to show that the association between HR-HPV infection and atherosclerotic cardiovascular mortality was present in both groups, with higher absolute rates among obese women.
Give yourself the academic edge today
Each order includes
- On-time delivery or your money back
- A fully qualified writer in your subject
- In-depth proofreading by our Quality Control Team
- 100% confidentiality, the work is never re-sold or published
- Standard 7-day amendment period
- A paper written to the standard ordered
- A detailed plagiarism report
- A comprehensive quality report
Enquire Now
